Skip to content

Study on the Effectiveness of High Definition-Transcranial Direct Current Stimulation (HD-tDCS) in Reducing Alcohol Cravings in People with Alcohol Dependence

Efficacy of High Definition-Transcranial Direct Current Stimulation (HD-tDCS) in Patients with Alcohol Dependence Syndrome (ADS) in Reducing Alcohol Cravings - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080084
Enrollment
50
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F- Physical Rehabilitation and Diagnostic Audiology

Interventions

Intervention1: High Definition-Transcranial Direct Current Stimulation (HD-tDCS): Active Stimulation: HD-tDCS Protocol: Participants will receive 20-minute sessions of HD-tDCS at 2 mA intensity, 5 day
beam F3), and 4 cathodes surrounding the area of stimulation. (during the trial/study of 6 months) Control Intervention1: High Definition-Transcranial Direct Current Stimulation (HD-tDCS): Sham timula
beam F3), and 4 cathodes surrounding the area of stimulation. (during the trial/study of 6 months)

Sponsors

Aditya Rajan Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (1) Met criteria for alcohol dependence according to the International Classification of Disorders. (ICD-10-CM Diagnosis Code F10.2) (2) Prior to participation, participants will give written, informed consent.

Exclusion criteria

Exclusion criteria: (1) A condition of intoxication or withdrawal due to a substance other than alcohol. (2) Diagnosis of epilepsy, convulsions, or delirium tremens during the abstinence of alcohol. (3) A previous history of drug hypersensitivity or adverse reactions to diazepam or other benzodiazepines and haloperidol. (4) Any contraindication for electrical brain stimulation procedures such as electronic or metal implants.

Design outcomes

Primary

MeasureTime frame
Demonstration of the effectiveness of HD-tDCS in reducing alcohol cravingsTimepoint: 3-point assessment will be done i.e., baseline, at the end of 2nd week & at the end of 4th week, during the trial.

Secondary

MeasureTime frame
Identification of tolerability, cognitive & emotional changes associated with HD-tDCS treatment.Timepoint: 3-point assessment will be done i.e., baseline, at the end of 2nd week & at the end of 4th week, during the trial.

Countries

India

Contacts

Public ContactDr Kanishk Kala

Shri Guru Ram Rai Institute of Medical Health & Sciences

shobit.garg@gmail.com8958534261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026